TUCSON, Ariz. (KGUN) — Diabetics have many options nowadays for their treatment plans. Afrezza is FDA-approved for adults with type 1 or type 2 diabetes as a fast-acting, mealtime insulin, but it ...

Trulicity (dulaglutide) is a brand-name injection prescribed to lower blood sugar levels and reduce the risk of certain cardiovascular problems. It works to treat these conditions by attaching to ...

As we are approaching the 100th anniversary of the discovery of insulin, a wide array of its signaling pathways has been defined. However, the initial step in insulin action, i.e. the engagement with ...

Automated insulin delivery (AID) systems, also known as hybrid closed loop systems, are changing the way type 1 diabetes is managed. These systems, which combine an insulin pump with a continuous ...

New research shows how zinc, pH levels and insulin work together to inhibit the buildup of protein clumps that contribute to Type 2 diabetes. An estimated 462 million people around the world suffer ...

Insulin remains one of the most important treatments for people living with diabetes. Whether someone has Type 1 diabetes or advanced Type 2 diabetes, insulin therapy helps control blood sugar levels, ...

Cipla, a global name in inhalation therapies, has announced the launch of Afrezza, the world’s only rapid-acting inhaled insulin, in India. The drug is approved for adults with type 1 and type 2 ...

More than 500 million people worldwide suffer from diabetes. Roughly 2.6 billion are overweight. Something that both groups have in common is that the hormone insulinhormones does not work nearly as ...

In the search for better ways to treat diabetes, researchers at the University of Geneva have uncovered a promising new approach that could reshape how this disease is managed. At the center of their ...

Type 2 diabetes is the most common type of diabetes. It occurs when your blood has high levels of sugar, also known as glucose. This can cause your pancreas, which is the organ that produces insulin, ...